Sup-ER Splint for Children With Birth Related Brachial Plexus Injury
NCT ID: NCT01663428
Last Updated: 2017-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2012-07-31
2019-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sup-ER Splint
Experimental group that will receive Sup-ER splint.
Sup-ER Splint
Control (Currently accepted treatment)
Control group that will receive the currently accepted treatment.
Currently accepted treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sup-ER Splint
Currently accepted treatment
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Significant deficit in external rotation and/or supination of the affected limb based on clinical assessment using the Toronto Active Movement Scale at 6 weeks of age: External Rotation ≤ 2 and/or Supination ≤ 2
* Tightness in Passive Range of Motion of external rotation: any angle of less than 180°.
* Age 6-8 weeks for complete protocol fulfillment.
Exclusion Criteria
* Unwillingness or inability to comply with the requirements of this protocol.
6 Weeks
8 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's & Women's Health Centre of British Columbia
OTHER
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cynthia Verchere
Principle Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cynthia Verchere, MD FRCSC
Role: PRINCIPAL_INVESTIGATOR
University of British Columbia
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
SPLINTING FOR PERIPHERAL NERVE INJURY IN UPPER LIMB
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H12-00776
Identifier Type: -
Identifier Source: org_study_id